StonvexLoading…
StonvexCore line items from VNCE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $300.01M | $293.45M | $292.89M | $357.44M |
Operating Income | $9.24M | $-17.18M | $31.62M | $-25.42M |
Net Income | $6.38M | $-19.05M | $25.45M | $-38.35M |
EPS (Diluted) | $0.49 | $-1.51 | $2.04 | $-3.14 |
Total Assets | $225.04M | $222.74M | $225.15M | $303.35M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $498.00K | $607.00K | $357.00K | $1.08M |
Free Cash Flow OCF − CapEx | $-1.30M | $17.83M | $180.00K | $-22.04M |
Shares Outstanding | 12.85M | 12.76M | 12.51M | 12.34M |